Skip to main content

Articles

Page 2 of 63

  1. Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2 diabetes; however, their effect on arrhythmias is unclear. The purpos...

    Authors: Shinya Fujiki, Kenichi Iijima, Yoshihisa Nakagawa, Kazuyoshi Takahashi, Masaaki Okabe, Kengo Kusano, Shingen Owada, Yusuke Kondo, Kenichi Tsujita, Wataru Shimizu, Hirofumi Tomita, Masaya Watanabe, Morio Shoda, Masafumi Watanabe, Takashi Tokano, Toyoaki Murohara…
    Citation: Cardiovascular Diabetology 2024 23:224
  2. Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are glucose-lowering agents used for the treatment of type 2 diabetes mellitus, which also improve heart failure and decrease the r...

    Authors: Barbora Judita Kasperova, Milos Mraz, Petr Svoboda, Daniel Hlavacek, Helena Kratochvilova, Istvan Modos, Nikola Vrzackova, Peter Ivak, Petra Janovska, Tatyana Kobets, Jakub Mahrik, Martin Riecan, Lenka Steiner Mrazova, Viktor Stranecky, Ivan Netuka, Tomas Cajka…
    Citation: Cardiovascular Diabetology 2024 23:223
  3. Previous studies have shown that an elevated triglyceride-glucose (TyG) index was associated with all-cause mortality in both general adult individuals and critically ill adult patients. However, the relations...

    Authors: Qi Gao, Fan Luo, Hongxue Yu, Yuxin Lin, Ruqi Xu, Pingping Li, Yuping Zhang, Jiao Liu, Licong Su and Yanqin Li
    Citation: Cardiovascular Diabetology 2024 23:222
  4. The incidence of myocardial infarction (MI) and sudden cardiac death (SCD) is significantly higher in individuals with Type 2 Diabetes Mellitus (T2DM) than in the general population. Strategies for the prevent...

    Authors: Cristiane Lauretti, Graziella L. Antonio, Ariana E. Fernandes, Fernando G. Stocco, Adriana C. C. Girardi, Richard L. Verrier and Bruno Caramelli
    Citation: Cardiovascular Diabetology 2024 23:221
  5. Lower extremity peripheral artery disease (PAD) often results from atherosclerosis, and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). Individuals with T2DM exhibit a more severe manifes...

    Authors: Guillaume Mahé, Victor Aboyans, Emmanuel Cosson, Kamel Mohammedi, Gabrielle Sarlon-Bartoli, Damien Lanéelle, Tristan Mirault and Patrice Darmon
    Citation: Cardiovascular Diabetology 2024 23:220
  6. Diabetic peripheral neuropathy (DPN) is the most prevalent complication of diabetes, and has been demonstrated to be independently associated with cardiovascular events and mortality. This aim of this study wa...

    Authors: Xue-Ming Li, Ke Shi, Li Jiang, Jing Wang, Wei-Feng Yan, Yue Gao, Meng-Ting Shen, Rui Shi, Ge Zhang, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:217
  7. Pretransplant type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular and all-cause mortality after heart transplant (HT), but the underlying causes of this association remain unclear. The ...

    Authors: Liqi Cao, Chang Liu, Chulan Ou, Quanmei Ma, Huanwen Xu, Xiaodan Li, Yingying Bao, Rui Chen, Yuelong Yang, Min Wu and Hui Liu
    Citation: Cardiovascular Diabetology 2024 23:216
  8. Circulating atherogenic index of plasma (AIP) levels has been proposed as a novel biomarker for dyslipidemia and as a predictor of insulin resistance (IR) risk. However, the association between AIP and the inc...

    Authors: Longjie Qu, Shuang Fang, Zhen Lan, Shuai Xu, Jialiu Jiang, Yilin Pan, Yun Xu, Xiaolei Zhu and Jiali Jin
    Citation: Cardiovascular Diabetology 2024 23:215
  9. Various surrogate markers of insulin resistance have been developed, capable of predicting coronary artery disease (CAD) without the need to detect serum insulin. For accurate prediction, they depend only on g...

    Authors: Seyed Reza Mirjalili, Sepideh Soltani, Zahra Heidari Meybodi, Pedro Marques-Vidal, Danial Dehghani Firouzabadi, Reza Eshraghi, David Restrepo, Hamed Ghoshouni and Mohammadtaghi Sarebanhassanabadi
    Citation: Cardiovascular Diabetology 2024 23:214
  10. The triglyceride glucose (TyG) index, TyG-body mass index (TyG-BMI), and triglyceride-density lipoprotein cholesterol ratio (TG/HDL-C) are substitute indicators for insulin resistance (IR). This study aimed to...

    Authors: Zijing Zhou, Qiang Liu, Min Zheng, Zhihong Zuo, Guogang Zhang, Ruizheng Shi and Ting Wu
    Citation: Cardiovascular Diabetology 2024 23:213
  11. This study sought to elucidate the associations of cardiometabolic index (CMI), as a metabolism-related index, with all-cause and cardiovascular mortality among the older population. Utilizing data from the Na...

    Authors: Bin Xu, Qian Wu, Rui La, Lingchen Lu, Fuad A. Abdu, Guoqing Yin, Wen Zhang, Wenquan Ding, Yicheng Ling, Zhiyuan He and Wenliang Che
    Citation: Cardiovascular Diabetology 2024 23:212
  12. Recently deorphanized G protein-coupled receptor 146 (GPR146) was shown to respond to signal from a newly identified hormone—cholesin—and to play a role in hepatic lipid metabolism. However, the importance of ...

    Authors: Aleksandra Ryk, Anna Marcinkiewicz, Jędrzej Chrzanowski, Arkadiusz Mariusz Michalak, Izabela Dróżdz, Jacek Burzyński, Michał Krejca and Wojciech Fendler
    Citation: Cardiovascular Diabetology 2024 23:211
  13. Stress hyperglycemia occurs frequently in patients following acute myocardial infarction (AMI) and may aggravate myocardial stiffness, but relevant evidence is still lacking. Accordingly, this study aimed to e...

    Authors: Pei-Lun Han, Kang Li, Yu Jiang, Yue Gao, Ying-Kun Guo, Zhi-Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2024 23:210
  14. To evaluate the association between diabetic foot disease (DFD) and the incidence of fatal and non-fatal events in individuals with type 2 diabetes (T2DM) from primary-care settings.

    Authors: Bogdan Vlacho, Magdalena Bundó, Judit Llussà, Jordi Real, Manel Mata-Cases, Xavier Cos, Diana Tundidor, Francesco Zaccardi, Kamlesh Khunti, Edward B. Jude, Josep Franch-Nadal and Dídac Mauricio
    Citation: Cardiovascular Diabetology 2024 23:209
  15. Triglyceride glucose (TyG) index and its related parameters have been introduced as cost-effective surrogate indicators of insulin resistance, while prospective evidence of their effects on atherosclerotic car...

    Authors: Xue Xia, Shuohua Chen, Xue Tian, Qin Xu, Yijun Zhang, Xiaoli Zhang, Jing Li, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2024 23:208
  16. Despite the high burden of obesity and Type 2 diabetes (T2DM) in the Middle East/West Asia region, the effect of weight change on the development of T2DM is poorly addressed. Therefore, we aimed to assess the ...

    Authors: Samaneh Asgari, Davood Khalili, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2024 23:207
  17. Elevated plasma glucose levels are common in patients suffering acute ischemic stroke (AIS), and acute hyperglycemia has been defined as an independent determinant of adverse outcomes. The impact of acute-to-c...

    Authors: Elisenda Climent, Ana Rodriguez-Campello, Joan Jiménez-Balado, Mercè Fernández-Miró, Jordi Jiménez-Conde, Gemma Llauradó, Ángel Ois, Juana A. Flores, Elisa Cuadrado-Godia, Eva Giralt Steinhauer and Juan J. Chillarón
    Citation: Cardiovascular Diabetology 2024 23:206
  18. There has been a substantial increase in the use of laparoscopic sleeve gastrectomy (SG) to treat morbid obesity despite observational evidence demonstrating the superiority of Roux-en-Y gastric bypass (RYGB) ...

    Authors: David Benaiges, Albert Goday, Anna Casajoana, Juana A. Flores-Le Roux, Montserrat Fitó, Oscar J. Pozo, Carme Serra, Manuel Pera, Gemma Llauradó, Elisenda Climent, Montserrat Villatoro, Iolanda Lazaro, Olga Castañer and Juan Pedro-Botet
    Citation: Cardiovascular Diabetology 2024 23:205
  19. Diabetic kidney disease is an established risk factor for heart failure. However, the impact of incident heart failure on the subsequent risk of renal failure has not been systematically assessed in diabetic p...

    Authors: Sylvia Liu, Jian-Jun Liu, Keven Ang, Janus Lee, Clara Chan, Resham L. Gurung, Huili Zheng, Justin Tang and Su Chi Lim
    Citation: Cardiovascular Diabetology 2024 23:204
  20. Stroke is a common complication of hypertension, but the predictive value of metabolic syndrome parameters' variability on stroke risk in individuals with hypertension remains unclear. Therefore, our objective...

    Authors: Qitong Liu, Shouling Wu, Jinang Shao, Yang Liu, Yanqiu Lu, Hao Wu, Yan Tian, Yanan Ma and Jingli Gao
    Citation: Cardiovascular Diabetology 2024 23:203
  21. The specific pathophysiological pathways through which diabetes exacerbates myocardial ischemia/reperfusion (I/R) injury remain unclear; however, dysregulation of immune and inflammatory cells, potentially dri...

    Authors: De-Zhao Liu, Xiao-Zhi Luo, Chuang-Hong Lu, Yang-Yi Feng, De-Xin Chen, Zhi-Yu Zeng and Feng Huang
    Citation: Cardiovascular Diabetology 2024 23:202
  22. It’s unclear if excess visceral adipose tissue (VAT) mass in individuals with prediabetes can be countered by adherence to a Mediterranean lifestyle (MEDLIFE). We aimed to examine VAT mass, MEDLIFE adherence, ...

    Authors: Hao-Wen Chen, Kuan Liu, Bi-Fei Cao, Qi Zhong, Rui Zhou, Liang-Hua Li, Shi-Ao Wang, Yan-Fei Wei, Hua-Min Liu and Xian-Bo Wu
    Citation: Cardiovascular Diabetology 2024 23:201
  23. There is currently limited understanding of the relationship between copeptin, the midregional portion of proadrenomedullin (MRproADM) and the midregional fragment of the N-terminal of proatrial natriuretic pe...

    Authors: Lee Ti Davidson, Jan Engvall, Simona I. Chisalita, Carl Johan Östgren and Fredrik H. Nyström
    Citation: Cardiovascular Diabetology 2024 23:200
  24. Metformin and sodium-glucose-cotransporter-2 inhibitors (SGLT2i) are cornerstone therapies for managing hyperglycemia in diabetes. However, their detailed impacts on metabolic processes, particularly within th...

    Authors: Makoto Harada, Jonathan Adam, Marcela Covic, Jianhong Ge, Stefan Brandmaier, Caroline Muschet, Jialing Huang, Siyu Han, Martina Rommel, Markus Rotter, Margit Heier, Robert P. Mohney, Jan Krumsiek, Gabi Kastenmüller, Wolfgang Rathmann, Zhongmei Zou…
    Citation: Cardiovascular Diabetology 2024 23:199
  25. The TIM-HF2 study demonstrated that remote patient management (RPM) in a well-defined heart failure (HF) population reduced the percentage of days lost due to unplanned cardiovascular hospital admissions or al...

    Authors: Friedrich Koehler, Johanna Koehler, Peter Bramlage, Eik Vettorazzi, Karl Wegscheider, Susanne Lezius, Sebastian Spethmann, Roman Iakoubov, Anjaly Vijayan, Sebastian Winkler, Christoph Melzer, Katharina Schütt, Cécile Dessapt-Baradez, W.Dieter Paar, Kerstin Koehler and Dirk Müller-Wieland
    Citation: Cardiovascular Diabetology 2024 23:198
  26. Sodium glucose cotransporter 2 (SGLT2) inhibitors significantly improve cardiovascular outcomes in diabetic patients; however, the mechanism is unclear. We hypothesized that dapagliflozin improves cardiac outc...

    Authors: Dennis D. Wang, Anna V. Naumova, Daniel Isquith, Jamie Sapp, Kim A. Huynh, Isabella Tucker, Niranjan Balu, Anna Voronyuk, Baocheng Chu, Karen Ordovas, Charles Maynard, Rong Tian, Xue-Qiao Zhao and Francis Kim
    Citation: Cardiovascular Diabetology 2024 23:197
  27. Monocytes play a central role in the pathophysiology of cardiovascular complications in type 2 diabetes (T2D) patients through different mechanisms. We investigated diabetes-induced changes in lncRNA genes fro...

    Authors: Najeeb Halabi, Binitha Thomas, Omar Chidiac, Amal Robay, Julien AbiNahed, Amin Jayyousi, Jassim Al Suwaidi, Martina Bradic and Charbel Abi Khalil
    Citation: Cardiovascular Diabetology 2024 23:196
  28. Micro- and macrovascular diseases are common in patients with type 2 diabetes mellitus (T2D) and may be partly caused by nocturnal hypoxemia. The study aimed to characterize the composition of nocturnal hypoxe...

    Authors: Sarah Driendl, Stefan Stadler, Michael Arzt, Florian Zeman, Iris M. Heid and Mathias Baumert
    Citation: Cardiovascular Diabetology 2024 23:195
  29. Recent studies have suggested that insulin resistance (IR) contributes to the development of cardiovascular diseases (CVD), and the estimated glucose disposal rate (eGDR) is considered to be a reliable surroga...

    Authors: Zenglei Zhang, Lin Zhao, Yiting Lu, Yan Xiao and Xianliang Zhou
    Citation: Cardiovascular Diabetology 2024 23:194
  30. Cardiovascular disease (CVD) is closely associated with the triglyceride glucose (TyG) index and its related indicators, particularly its combination with obesity indices. However, there is limited research on...

    Authors: Xiaoqing Zhu, Weihao Xu, Tingting Song, Xinyan Wang, Qingsong Wang, Jun Li, Xixi Liu, Benchuan Hao, Tao Chen and Jun Guo
    Citation: Cardiovascular Diabetology 2024 23:192
  31. The purpose of this study was to explore the prognostic significance of the lesion-specific pericoronary fat attenuation index (FAI) in forecasting major adverse cardiovascular events (MACE) among patients wit...

    Authors: Meiju Liu, Yanhua Zhen, Jin Shang, Yuxue Dang, Qian Zhang, Weishi Ni, Yujuan Qiao and Yang Hou
    Citation: Cardiovascular Diabetology 2024 23:191
  32. Coronary three-vessel disease (CTVD) accounts for one-third of the overall incidence of coronary artery disease, with heightened mortality rates compared to single-vessel lesions, including common trunk lesion...

    Authors: Zheng Qiao, Xiaohui Bian, Chenxi Song, Rui Zhang, Sheng Yuan, Zhangyu Lin, Chenggang Zhu, Qianqian Liu, Wenjun Ma and Kefei Dou
    Citation: Cardiovascular Diabetology 2024 23:190
  33. Authors: Aftab Ahmad and Hani Sabbour
    Citation: Cardiovascular Diabetology 2024 23:189

    The original article was published in Cardiovascular Diabetology 2024 23:99

  34. Insulin resistance (IR) plays a vital role in the pathogenesis of the metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether triglyceride–glucose (TyG) related pa...

    Authors: Yu Min, Xiaoyuan Wei, Zhigong Wei, Ge Song, Xin Zhao and Yi Lei
    Citation: Cardiovascular Diabetology 2024 23:188
  35. Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resis...

    Authors: Wen Zhang, Lu Liu, Guoqing Yin, Abdul-Quddus Mohammed, Lanqing Xiang, Xian Lv, Tingting Shi, Jassur Galip, Chunyue Wang, Ayman A. Mohammed, Redhwan M. Mareai, Fei Yu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2024 23:187
  36. Vascular calcification (VC) is an independent risk factor for cardiovascular diseases. Recently, ferroptosis has been recognised as a novel therapeutic target for cardiovascular diseases. Although an associati...

    Authors: Yierpani Aierken, Huqiang He, Runwen Li, Zipeng Lin, Tongjie Xu, Li Zhang, Ya Wu and Yong Liu
    Citation: Cardiovascular Diabetology 2024 23:186
  37. Triglyceride and glucose (TyG) index, a surrogate marker of insulin resistance, has been validated as a predictor of cardiovascular disease. However, effects of TyG-related indices combined with obesity marker...

    Authors: Cancan Cui, Yitian Qi, Jiayin Song, Xinyun Shang, Tianjiao Han, Ning Han, Siqi Yue, Yining Zha, Zhonghang Xu, Jiannan Li and Lin Liu
    Citation: Cardiovascular Diabetology 2024 23:185
  38. Use of sodium-glucose-cotransporter-2 (SGLT2) inhibitors often causes an initial decline in glomerular filtration rate (GFR). This study addresses the question whether the initial decline of renal function wit...

    Authors: Merve Günes-Altan, Agnes Bosch, Kristina Striepe, Peter Bramlage, Mario Schiffer, Roland E. Schmieder and Dennis Kannenkeril
    Citation: Cardiovascular Diabetology 2024 23:184
  39. People with type 2 diabetes (T2D) are at elevated risk of cardiovascular disease (CVD) including stroke, yet existing real-world evidence (RWE) on the clinical and economic burden of stroke in this population ...

    Authors: Kamel Mohammedi, Laurent Fauchier, Nadia Quignot, Artak Khachatryan, Tamar Banon, Raissa Kapnang, Kazue Kikuchi, Hongye Ren, Christine Massien, Lucile Vigié, Sara Larsen and Igor Sibon
    Citation: Cardiovascular Diabetology 2024 23:183
  40. Left ventricular global longitudinal strain (GLS) holds greater diagnostic and prognostic value than left ventricular ejection fraction (LVEF) in the heart failure (HF) patients. The triglyceride-glucose (TyG)...

    Authors: Shuai Zhang, Yan Liu, Fangfang Liu, Qing Ye, Dachuan Guo, Panpan Xu, Tianhao Wei, Cheng Zhang and Huixia Lu
    Citation: Cardiovascular Diabetology 2024 23:182
  41. Atherosclerosis is the main cause of stroke and coronary heart disease (CHD), both

    Authors: Mohamed A. Elhadad, Mónica del C. Gómez-Alonso, Chien-Wei Chen, Sonja Neumeyer, Thomas Delerue, Wolfgang Rathmann, Michael Näbauer, Christa Meisinger, Stefan Kääb, Jochen Seissler, Johannes Graumann, Wolfgang Koenig, Karsten Suhre, Christian Gieger, Uwe Völker, Annette Peters…
    Citation: Cardiovascular Diabetology 2024 23:181
  42. Authors: Gaetano Santulli, Valeria Visco, Michele Ciccarelli, Mario Nicola Vittorio Ferrante, Piero De Masi, Antonella Pansini, Nicola Virtuoso, Armando Pirone, Germano Guerra, Veronica Verri, Gaetano Macina, Alessandro Taurino, Klara Komici and Pasquale Mone
    Citation: Cardiovascular Diabetology 2024 23:180

    The original article was published in Cardiovascular Diabetology 2024 23:125

  43. Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio...

    Authors: Kairui Bo, Weibo Li, Hongkai Zhang, Yan Wang, Zhen Zhou, Yifeng Gao, Zhonghua Sun, Jianxiu Lian, Hui Wang and Lei Xu
    Citation: Cardiovascular Diabetology 2024 23:179
  44. Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with Type 1 Diabetes (T1D). Early markers of CVD include increased carotid intima-media thickness (CIMT) and pulse ...

    Authors: Michael J. De Biasio, Michelle Furman, Antoine Clarke, Wei Hui, Yesmino Elia, Jerome Baranger, Olivier Villemain, Luc Mertens and Farid H. Mahmud
    Citation: Cardiovascular Diabetology 2024 23:178
  45. Numerous meta-analyses have explored the association between the triglyceride-glucose (TyG) index and diverse health outcomes, yet the comprehensive assessment of the scope, validity, and quality of this evide...

    Authors: Jia-Li Yin, Jing Yang, Xin-Jian Song, Xue Qin, Yu-Jiao Chang, Xing Chen, Fang-Hua Liu, Yi-Zi Li, He-Li Xu, Yi-Fan Wei, Fan Cao, Xue-Li Bai, Lang Wu, Tao Tao, Jian Du, Ting-Ting Gong…
    Citation: Cardiovascular Diabetology 2024 23:177
  46. There is conflicting evidence whether prediabetes is associated with adverse clinical outcomes in patients with chronic coronary syndrome. We aimed to assess the effect of prediabetes in patients with chronic ...

    Authors: Anselm Jorda, Christian Hengstenberg, Irene M. Lang, Alexandra Kautzky-Willer, Jürgen Harreiter, Markus Zeitlinger, Bernd Jilma and Georg Gelbenegger
    Citation: Cardiovascular Diabetology 2024 23:176
  47. Insulin resistance (IR) is the cornerstone of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), pathophysiologically being the key link between MASLD, metabolic disorders, and cardiovascular (C...

    Authors: Alessandra Colantoni, Tommaso Bucci, Nicholas Cocomello, Francesco Angelico, Evaristo Ettorre, Daniele Pastori, Gregory Y.H. Lip, Maria Del Ben and Francesco Baratta
    Citation: Cardiovascular Diabetology 2024 23:175

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 8.9
    Source Normalized Impact per Paper (SNIP): 1.855
    SCImago Journal Rank (SJR): 2.621

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 56

    Usage 2023
    Downloads: 2,523,778
    Altmetric mentions: 3,115